Exabeam’s Findlay Whitelaw says the Australian Medicare incident highlights the need for monitoring and accountability as AI ...

This week's top stories include Basecamp Research's funding round, a warning from Europe's pharma chiefs and Roche and ...

Glenn Hunzinger, Health Industries Lead at PwC, discusses the challenges and opportunities of taking personalised mRNA cancer ...

Encouraging Phase 2 results show a robust immune response against serotype 3, prompting pivotal Phase 3 trials to protect up to 90% of paediatric patients Pfizer has announced the advancement of its ...

European pharma leaders have sounded the alarm over Europe’s declining competitiveness, warning that the continent is “losing ...

As payers, health systems and pharmaceutical giants compete to modernise patient experience, expedite drug development and keep pace with a rapidly evolving tech landscape, the Chief Digital Officer ...

WHO appoints Dr Vanessa Kerry to advance resilient health systems, sustainable financing and climate resilience, amid ...

Iambic's technology is intended to complement the expertise of AbbVie's existing discovery teams rather than operate independently of them. Credit: AbbVie Nicholas Donoghoe, AbbVie’s Chief Business ...

Lykke Hinsch Gylvin explains how Boehringer Ingelheim’s PED Essentials aims to turn patient experience into evidence that can ...

Mitie becomes a central partner at Macclesfield campus, one of AstraZeneca’s most significant global manufacturing and technology sites Innovation in healthcare is a long-standing necessity, and often ...